Dr. Filemon Dela Cruz, a pediatric hematologist-oncologist at MSK, shared his poster on “Preclinical evaluation of PEG-[SN22]₄ (PEEL-224)...

Memorial Sloan Kettering Cancer Center· @MSKCancerCenter · X·2026-04-21 22:00· 2026-04-21Score60

Body · original

Dr. Filemon Dela Cruz, a pediatric hematologist-oncologist at MSK, shared his poster on “Preclinical evaluation of PEG-[SN22]₄ (PEEL-224), a multivalent polymeric camptothecin prodrug, in pediatric solid tumor patient-derived xenograft models” during #AACR26.
@aacr

Heat 8 · 7 likes · 0 replies · 1 repost

Conference abstracts

1157NCT05329103 NCT06709495 NCT06721689matched by 代号 PEEL-224

Preclinical evaluation of PEG-[SN22]4 (PEEL-224), a multivalent polymeric camptothecin prodrug, in pediatric solid tumor patient-derived xenograft models

Filemon S. Dela Cruz, Kristina C. Guillan, Samantha Brosius, Armaan H. Siddiquee, Glorife Ibanez Sanchez, Daoqi You, Kristen Victor, Paul Calder, Trent Fowler, Joshua D. Schiffman, Andrew L. Kung

Read the abstract →

Source: Memorial Sloan Kettering Cancer Center · x.com